Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of ABN401 in Advanced Solid Tumors With c-MET Gene Aberration (KOSMOS-II)
KCT0008450Phase 2Not yet recruiting
- Sponsor
- ABION Inc.
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vabametkib in Nonhematologic neoplasms, sponsored by ABION Inc.. Planned start May 2023; status: not yet recruiting.
02
Drugs
vabametkib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on KCT0008450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008450.